Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1609575, 16 pages
https://doi.org/10.1155/2017/1609575
Review Article

New Insights into the Epigenetics of Hepatocellular Carcinoma

1Centre for Applied Molecular Biology, 87 West Canal Bank Road Thokar Niaz Baig, University of the Punjab, Lahore, Pakistan
2Hazara University, Mansehra, Pakistan

Correspondence should be addressed to Amjad Ali; kp.ude.up@bmac.dajma

Received 26 August 2016; Accepted 17 January 2017; Published 19 March 2017

Academic Editor: Mario Scartozzi

Copyright © 2017 Braira Wahid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [33 citations]

The following is the list of published articles that have cited the current article.

  • Ji Hu, Peng Li, Yang Song, Yun-xuan Ge, Xiao-ming Meng, Cheng Huang, Jun Li, and Tao Xu, “Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function,” Journal of Cellular Physiology, 2017. View at Publisher · View at Google Scholar
  • Hege Marie Vedeld, Ajay Goel, and Guro E. Lind, “Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives,” Seminars in Cancer Biology, 2017. View at Publisher · View at Google Scholar
  • Mrigaya Mehra, and Ranjit Chauhan, “Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma,” Biomarkers in Cancer, vol. 9, pp. 1179299X1773730, 2017. View at Publisher · View at Google Scholar
  • Zhifei Lin, Jubo Zhang, Huliang Jia, Yahui Zheng, Xudong Ren, Wenwei Zhu, Jinhong Chen, Liang Hong, Weiqin Shao, Lu Lu, and Ming Lu, “Prognostic impact of SET domain‑containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection,” Oncology Letters, vol. 16, no. 3, pp. 3665–3673, 2018. View at Publisher · View at Google Scholar
  • Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, and Marta Chagas Monteiro, “Epigenetic Alterations Caused By Aflatoxin B1: A Public Health Risk In The Induction Of Hepatocellular Carcinoma,” Translational Research, 2018. View at Publisher · View at Google Scholar
  • Leilei Bao, Guoshan Ding, Quanxiang Wang, Mingjian Zhang, Shu Han, Meng Guo, Luding Zhang, Yangyang Zhan, Wenyuan Guo, Fei Teng, and Fang Liu, “MicroRNA-500a promotes the progression of hepatocellular carcinoma by post-transcriptionally targeting BID,” Cellular Physiology and Biochemistry, vol. 47, no. 5, pp. 2046–2055, 2018. View at Publisher · View at Google Scholar
  • Mohamed A. Mekky, Rgaa H. Salama, Mahmoud F. Abdel-Aal, Mohamed A. Ghaliony, and Saad Zaky, “Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesis,” Cancer Biomarkers, pp. 1–7, 2018. View at Publisher · View at Google Scholar
  • Zhuohong Li, Yu Chen, Xiuyun He, Chaofu Zhu, Baiping An, Lin Qian, Lan Lan, and Shijie Li, “Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells,” OncoTargets and Therapy, vol. 11, pp. 2937–2944, 2018. View at Publisher · View at Google Scholar
  • Masa-Aki Shibata, Yoshinori Otsuki, Yoichi Kondo, Kentaro Maemura, Michihiro Hayashi, Kazuhisa Uchiyama, Yutaka Mizuno, Yoshihisa Tanaka, Azumi Hirata, Sugiko Futaki, Hiroki Hamamoto, and Kohei Taniguchi, “Expression of delta-like 3 is downregulated by aberrant DNA methylation and histone modification in hepatocellular carcinoma,” Oncology Reports, vol. 39, no. 5, pp. 2209–2216, 2018. View at Publisher · View at Google Scholar
  • Cristina Di Poto, Shisi He, Rency S. Varghese, Yi Zhao, Alessia Ferrarini, Shan Su, Abdullah Karabala, Mesfin Redi, Hassen Mamo, Amol S. Rangnekar, Thomas M. Fishbein, Alexander H. Kroemer, Mahlet G. Tadesse, Rabindra Roy, Zaki A. Sherif, Deepak Kumar, and Habtom W. Ressom, “Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection,” Plos One, vol. 13, no. 3, pp. e0192748, 2018. View at Publisher · View at Google Scholar
  • Ying Chen, Zetian Shen, Yingru Zhi, Hao Zhou, Kai Zhang, Ting Wang, Bing Feng, Yitian Chen, Haizhu Song, Rui Wang, and Xiaoyuan Chu, “Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression,” Archives of Biochemistry and Biophysics, 2018. View at Publisher · View at Google Scholar
  • Gao Ning, Yang Wei, Yan Yanfeng, and Xu Jing, “Methylation status of MEG3 promoter in hepatocellular carcinoma and its clinical significance,” Cancer Research and Clinic, vol. 30, no. 2, pp. 85–88, 2018. View at Publisher · View at Google Scholar
  • Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, and George G. Chen, “Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies,” Therapeutic Advances in Medical Oncology, vol. 10, pp. 175883591881628, 2018. View at Publisher · View at Google Scholar
  • Tae-Su Han, Hyun Seung Ban, Keun Hur, and Hyun-Soo Cho, “The Epigenetic Regulation of HCC Metastasis,” International Journal of Molecular Sciences, vol. 19, no. 12, pp. 3978, 2018. View at Publisher · View at Google Scholar
  • Matthew Hoare, “Mechanisms of Disease: The Damaged Genome in HCC,” Liver Cancers, pp. 39–58, 2018. View at Publisher · View at Google Scholar
  • Renumathy Dhanasekaran, Jean-Charles Nault, Lewis R. Roberts, and Jessica Zucman-Rossi, “Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy,” Gastroenterology, 2018. View at Publisher · View at Google Scholar
  • Yang Wang, Tong Deng, Xue-Qun Ren, Bing-Hui Li, Chao-Yang Wang, and Ming-Juan Zhao, “Up-regulation of phosphatase in regenerating Liver-3 (PRL-3) contributes to malignant progression of hepatocellular carcinoma by activating phosphatase and tensin homolog deleted on chromosome ten (PTEN)/phosphoinositide 3-kinase (PI3K)/AKT signaling pathway,” Medical Science Monitor, vol. 24, pp. 8105–8114, 2018. View at Publisher · View at Google Scholar
  • Jianlin Wang, Kefeng Dou, Xisheng Yang, Runze Shang, Zhen Yang, Kaishan Tao, Congcong Xia, Meng Pu, Bin Dai, and Ruohan Zhang, “Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma,” Oncology Reports, vol. 40, no. 4, pp. 1875–1884, 2018. View at Publisher · View at Google Scholar
  • Xin-Yu Bian, Wei-Zhong Wu, Dong-Min Shi, and Cheng-Dong Qin, “miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway,” OncoTargets and Therapy, vol. 11, pp. 571–585, 2018. View at Publisher · View at Google Scholar
  • Venkat Bhat, Sujitha Srinathan, Elisa Pasini, Marc Angeli, Emily Chen, Cristina Baciu, and Mamatha Bhat, “Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis,” World Journal of Hepatology, vol. 10, no. 1, pp. 155–165, 2018. View at Publisher · View at Google Scholar
  • Fu Xiong, Yin Jin, Chuansheng Zheng, Qiaoyou Weng, Jingjing Song, Guofeng Zhou, David Shin, Feng Zhang, and Xiaoming Yang, “Orthotopic hepatic cancer: Radiofrequency hyperthermiaenhanced intratumoral herpes simplex virus-thymidine kinase gene therapy,” Oncotarget, vol. 9, no. 18, pp. 14099–14108, 2018. View at Publisher · View at Google Scholar
  • Hai-Rong Zhu, Ren-Zheng Huang, Xiang-Nan Yu, Xuan Shi, Enkhnaran Bilegsaikhan, Hong-Ying Guo, Guang-Qi Song, Shu-Qiang Weng, Ling Dong, Harry L.A. Janssen, Xi-Zhong Shen, and Ji-Min Zhu, “Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma,” The Tohoku Journal of Experimental Medicine, vol. 245, no. 2, pp. 89–98, 2018. View at Publisher · View at Google Scholar
  • Yehuda G. Assaraf, Anamaria Brozovic, Ana Cristina Gonçalves, Dana Jurkovicova, Aija Linē, Miguel Machuqueiro, Simona Saponara, Ana Bela Sarmento-Ribeiro, Cristina P.R. Xavier, and M. Helena Vasconcelos, “The multi-factorial nature of clinical multidrug resistance in cancer,” Drug Resistance Updates, pp. 100645, 2019. View at Publisher · View at Google Scholar
  • Sebastião N. Martins-Filho, and Venâncio Avancini Ferreira Alves, “The strengths and weaknesses of gross and histopathological evaluation in hepatocellular carcinoma: a brief review,” Surgical and Experimental Pathology, vol. 2, no. 1, 2019. View at Publisher · View at Google Scholar
  • Ramesh C. Kovi, Sachin Bhusari, Deepak Mav, Ruchir R. Shah, Thai Vu Ton, Mark J. Hoenerhoff, Robert C. Sills, and Arun R. Pandiri, “Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice,” Archives of Toxicology, 2019. View at Publisher · View at Google Scholar
  • Joanne Trinh, Krishna Kumar Kandaswamy, Martin Werber, Maximilian E. R. Weiss, Gabriela Oprea, Shivendra Kishore, Katja Lohmann, and Arndt Rolfs, “Novel pathogenic variants and multiple molecular diagnoses in neurodevelopmental disorders,” Journal of Neurodevelopmental Disorders, vol. 11, no. 1, 2019. View at Publisher · View at Google Scholar
  • Tan Boon Toh, Jhin Jieh Lim, and Edward Kai-Hua Chow, “Epigenetics of hepatocellular carcinoma,” Clinical and Translational Medicine, vol. 8, no. 1, 2019. View at Publisher · View at Google Scholar
  • Jai‐Jen Tsai, Jiann‐hwa Chen, Cheng Hsien Chen, Jing‐Gung Chung, and Fei‐Ting Hsu, “ Apoptosis induction and ERK/NF‐κB inactivation are associated with magnolol‐inhibited tumor progression in hepatocellular carcinoma in vivo ,” Environmental Toxicology, 2019. View at Publisher · View at Google Scholar
  • Jia-Jun Lu, and Zhou Yuan, “Application of DNA methylation in early diagnosis and treatment of pancreatic cancer,” World Chinese Journal of Digestology, vol. 27, no. 1, pp. 13–19, 2019. View at Publisher · View at Google Scholar
  • Peng-Peng Li, Jia-Pei Guo, Bin Guo, Hong-Bin Jiao, Jing-Hua Wu, Jun-Mao Chen, Dian-Xing Liu, and Lei-Lei Li, “Exosomes derived from HBV-associated liver cancer promote chemoresistance by upregulating chaperone-mediated autophagy,” Oncology Letters, vol. 17, no. 1, pp. 323–331, 2019. View at Publisher · View at Google Scholar
  • Jun Zhao, Steven G. Gray, Catherine M. Greene, and Matthew W. Lawless, “Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer,” Expert Review of Gastroenterology & Hepatology, pp. 1–10, 2019. View at Publisher · View at Google Scholar
  • Shahrzad Movafagh, and Amanda Munson, “Histone Deacetylase Inhibitors in Cancer Prevention and Therapy,” Epigenetics of Cancer Prevention, pp. 75–105, 2019. View at Publisher · View at Google Scholar
  • Jianlin Wang, Congcong Xia, Xisheng Yang, Kefeng Dou, Haimin Li, Bin Dai, and Kaishan Tao, “Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1,” OncoTargets and Therapy, vol. 12, pp. 869–882, 2019. View at Publisher · View at Google Scholar